Biblio

Journal Article
Skrbo N, Tenstad E, Mælandsmo GM, Sørlie T, Andersen K. From autonomy to community; new perspectives on tumorigenicity and therapy resistance. Cancer Treat Rev. 2015.
Görgens A, Horn PA. From Basic Biology to Engineering and Clinical Translation of Stem Cells: Meeting Report on the 8th International Meeting of the Stem Cell Network North Rhine Westphalia. Cell Reprogram. 2015.
Cabrera-Fuentes HA, Aragones J, Bernhagen J, Boening A, Boisvert WA, Bøtker HE, Bulluck H, Cook S, Di Lisa F, Engel FB, et al. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research". Basic Res Cardiol. 2016;111(6):69.
Xiao H, Rosen A, Chhibbar P, Moise L, Das J. From bench to bedside via bytes: Multi-omic immunoprofiling and integration using machine learning and network approaches. Hum Vaccin Immunother. 2023;19(3):2282803.
Knoepfler PS. From Bench to FDA to Bedside: US Regulatory Trends for New Stem Cell Therapies. Adv Drug Deliv Rev. 2014.
Pereira C-F, Lemischka IR, Moore K. 'From blood to blood': de-differentiation of hematopoietic progenitors to stem cells. EMBO J. 2014.
Liu L, Eckert MA, Riazifar H, Kang D-K, Agalliu D, Zhao W. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier?. Stem Cells Int. 2013;2013:435093.
Gurnari C, Visconte V. From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers. Leuk Res. 2023;127:107038.
Ferrari E, Cardinale A, Picconi B, Gardoni F. From cell lines to pluripotent Stem Cells for Modelling Parkinson's Disease. J Neurosci Methods. 2020:108741.
Suissa JS, Friedman WE. From cells to stems: the effects of primary vascular construction on drought-induced embolism in fern rhizomes. New Phytol. 2021.
Lorenz J, Waldschmidt J, Wider D, Follo M, Ihorst G, Chatterjee M, May AM, Duyster J, Rosenwald A, Wäsch R, et al. From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration. Br J Haematol. 2015.
Padgett J, Santos SDm. From clocks to dominoes: lessons on cell cycle remodelling from embryonic stem cells. FEBS Lett. 2020.
Joyner AL. From Cloning Neural Development Genes to Functional Studies in Mice, 30 Years of Advancements. Curr Top Dev Biol. 2016;116:501-515.
Imodoye SO, Adedokun KA, Bello IO. From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy. Histochem Cell Biol. 2024.
Reichman S, Terray A, Slembrouck A, Nanteau C, Orieux G, Habeler W, Nandrot EF, Sahel J-A, Monville C, Goureau O. From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium. Proc Natl Acad Sci U S A. 2014.
Bergsma AJ, Groen SLm In 't, Verheijen FW, van der Ploeg AT, Pijnappel WPim. From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides. Mol Ther Nucleic Acids. 2016;5(9):e361.
Zhao D, Farnell MB, Kogut MH, Genovese KJ, Chapkin RS, Davidson LA, Berghman LR, Farnell YZ. From crypts to enteroids: establishment and characterization of avian intestinal organoids. Poult Sci. 2021;101(3):101642.
Madamtzoglou D, Relaix F. From cyclins to CDKIs: Cell cycle regulation of skeletal muscle stem cell quiescence and activation. Exp Cell Res. 2022:113275.
Yoshida S. From cyst to tubule: innovations in vertebrate spermatogenesis. Wiley Interdiscip Rev Dev Biol. 2015.
Saini A, Mastana S, Myers F, Lewis MPeter. 'From Death, Lead Me to Immortality' - Mantra of Ageing Skeletal Muscle. Curr Genomics. 2013;14(4):256-267.
Choudhuri A, Han T, Zon LI. From development toward therapeutics, a collaborative effort on blood progenitors. Stem Cell Reports. 2021.
McNeish J, Gardner JP, Wainger BJ, Woolf CJ, Eggan K. From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial. Cell Stem Cell. 2015;17(1):8-10.
Anon. From disruptive to standard - making next-generation sequencing reliable: an interview with Christophe Roos. Expert Rev Mol Diagn. 2016.
Bazaz MRezazade, Dehghani H. From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods. Life Sci. 2022:120409.
Hu J, Wang J. From embryonic stem cells to induced pluripotent stem cells - ready for clinical therapy?. Clin Transplant. 2019:e13573.

Pages